Proton pump inhibitors

93 64 Pill - yellow round

Pill with imprint 93 64 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Rabeprazole is used in the treatment of Barrett's Esophagus; Duodenal Ulcer; Erosive Esophagitis; Duodenal Ulcer Prophylaxis; GERD and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Rabeprazole (Rabeprazole [ ra-bep-ra-zole ])-93 64-20 mg-Yellow-Round
Rabeprazole (Rabeprazole [ ra-bep-ra-zole ])-93 64-20 mg-Yellow-Round
Rabeprazole (Rabeprazole [ ra-bep-ra-zole ])-93 64-20 mg-Yellow-Round
Rabeprazole (Rabeprazole [ ra-bep-ra-zole ])-93 64-20 mg-Yellow-Round

Rabeprazole
Generic Name: rabeprazole [ ra-bep-ra-zole ]
Imprint: 93 64
Strength: 20 mg
Color: Yellow
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Proton pump inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: D&C Yellow No. 10, FD&C Yellow No. 6, Hydroxypropyl cellulose, Hypromelloses, Hypromellose 2910 (15 mPa.s), Ferrosoferric oxide, Lactose monohydrate, Low substituted hydroxypropyl cellulose, Magnesium oxide, Magnesium stearate, Mannitol, Microcrystalline cellulose, Polyethylene glycol 4000, Propylene glycol, Shellac, Stearic acid, Titanium dioxide, Triethyl citrate,
Latest News
Related Drugs